ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Astellas Pharma, Inc.
10.97
+0.1200
1.11%
成交量:
6.48万
成交额:
71.04万
市值:
204.24亿
市盈率:
147.54
高:
11.31
开:
10.53
低:
10.53
收:
10.85
52周最高:
13.14
52周最低:
8.37
股本:
18.62亿
流通股本:
17.31亿
量比:
0.48
换手率:
0.00%
股息:
0.50
股息率:
4.57%
每股收益(TTM):
0.0744
每股收益(LYR):
0.0628
净资产收益率:
5.17%
总资产收益率:
5.10%
市净率:
2.04
市盈率(LYR):
174.57
数据加载中...
总览
公司
新闻
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻
安斯泰来制药株式会社与株式会社安川电机新设合营企业案无条件批准
金融界
·
08/01
美国OTC市场安斯泰来制药盘中异动 早盘快速上涨5.26%
市场透视
·
07/30
美国OTC市场安斯泰来制药盘中异动 快速上涨6.73%报10.15美元
市场透视
·
07/14
三菱综合研究所与安斯泰来制药联手支持日本新药研发初创企业全球化
DoNews
·
06/13
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALPMY"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":10.97,"timestamp":1754683200000,"preClose":10.85,"halted":0,"volume":64760,"delay":15,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"盘前交易","change":0.12,"latestTime":"08-08 16:00:00 EDT 延时","open":10.5301,"high":11.312,"low":10.5301,"amount":710441.3749000002,"amplitude":0.072065,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754919000000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":10.97,"volumeRatio":0.4780648264064781},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","floatShares":1731101601,"roa":"5.10%","roe":"5.17%","lyrEps":0.062841,"volumeRatio":0.4780648264064781,"shares":1861787075,"dividePrice":0.500906,"high":11.312,"amplitude":0.072065,"preClose":10.85,"low":10.5301,"week52Low":8.37,"pbRate":"2.04","psRate":"1.55","week52High":13.14,"institutionHeld":0,"latestPrice":10.97,"eps":0.074352,"divideRate":0.045661,"volume":64760,"delay":15,"ttmEps":0.074352,"open":10.5301,"prevYearClose":9.66,"prevWeekClose":10.97,"prevMonthClose":10.34,"prevQuarterClose":9.75,"fiveDayClose":10.57,"twentyDayClose":9.51,"sixtyDayClose":9.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-04","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-01","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722499200000,"name":null,"time":"","dateTimestamp":1722484800000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1683000000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556914458","title":"安斯泰来制药株式会社与株式会社安川电机新设合营企业案无条件批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2556914458","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556914458?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 17:31","pubTimestamp":1754040692,"startTime":"0","endTime":"0","summary":"8月1日,根据国家市场监管总局公示,2025年7月21日—7月27日共有16件经营者集中案件获无条件批准。其中,安斯泰来制药株式会社与株式会社安川电机新设合营企业案获无条件批准,审结时间为2025年7月24日。该参与集中的经营者包括:安斯泰来制药株式会社,株式会社安川电机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801173556972c889c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801173556972c889c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2555028230","title":"美国OTC市场安斯泰来制药盘中异动 早盘快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555028230?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 22:56","pubTimestamp":1753887394,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时56分,美国OTC市场安斯泰来制药股票出现异动,股价快速拉升5.26%。截至发稿,该股报10.60美元/股,成交量4.2751万股,换手率0.00%,振幅2.22%。机构评级方面,在所有14家参与评级的机构中,36%的券商给予买入建议,57%的券商给予持有建议,7%的券商给予卖出建议。美国OTC市场安斯泰来制药股票所在的制药行业中,整体跌幅为0.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073022563497280385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073022563497280385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2551184645","title":"美国OTC市场安斯泰来制药盘中异动 快速上涨6.73%报10.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551184645?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 21:46","pubTimestamp":1752500768,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时46分,美国OTC市场安斯泰来制药股票出现异动,股价大幅拉升6.73%。截至发稿,该股报10.15美元/股,成交量3.53万股,换手率0.00%,振幅0.00%。美国OTC市场安斯泰来制药股票所在的制药行业中,整体涨幅为0.14%。其相关个股中,Mira Pharmaceuticals, Inc.、Tilray Brands, Inc.、Journey Medical Corporation涨幅较大,Incannex Healthcare Inc.、Mira Pharmaceuticals, Inc.、Evoke Pharma, Inc.较为活跃,换手率分别为43.00%、14.23%、7.67%,振幅较大的相关个股有Mira Pharmaceuticals, Inc.、Tilray Brands, Inc.、Journey Medical Corporation,振幅分别为23.44%、11.25%、11.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214608a44a243d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214608a44a243d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2543850356","title":"三菱综合研究所与安斯泰来制药联手支持日本新药研发初创企业全球化","url":"https://stock-news.laohu8.com/highlight/detail?id=2543850356","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543850356?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 17:38","pubTimestamp":1749807482,"startTime":"0","endTime":"0","summary":"三菱综合研究所(MRI)与安斯泰来制药公司宣布达成谅解备忘录,共同助力日本新药研发初创企业拓展全球市场。MRI将基于其在MEDISO项目中的经验,为参与企业量身定制支持方案。安斯泰来则提供实验室及办公空间,进一步推动MEDISO加速计划中的药物发现初创企业发展。此次合作旨在整合双方资源,为初创企业创造国际化机遇。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613174157977e077c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613174157977e077c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALPMY\",params:#limit:6,delay:false,,,undefined,":[]}}